Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DOCS vs FIGS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DOCS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

DOCS Overall Winner 6-Pillar Tally: DOCS 4 – 2 FIGS Matrix Metrics: DOCS 7 – 3 FIGS

As of Nov 16, 2026, Doximity, Inc. (DOCS) is the stronger overall head-to-head candidate over FIGS, Inc. (FIGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). DOCS carries a Unified Composite Score of 54.4/100 (HOLD) at $32.67 (20.6x Forward P/E, 27.1% operating margin), whereas FIGS carries 42.1/100 (HOLD) at $21.59 (50.8x Forward P/E, 9.7% operating margin).

  • Growth vs. Quality Trade-Off: DOCS earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. FIGS 42.1/100 HOLD) and 0.65β · 41% Vol risk profile, whereas FIGS leads top-line expansion (+25.7% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DOCS vs FIGS
DOCS NYSE Head-to-Head Winner
Doximity, Inc.
Services-Computer Programming Services
$32.67
-2.01% 1D
Market Cap $5.9B
TTM Revenue $662M
Forward P/E 20.6x
Beta / 30D Vol 0.65β · 41% Vol
Unified Composite Score
54.4 / 100 HOLD
Tech 39.0 Fund 51.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (11.2% over 20 days), RSI 54
RSI-14: 53.6 · SMA20: $33.23 · SMA50: $29.86
FIGS NYSE
FIGS, Inc.
Apparel & Other Finishd Prods Of Fabrics & Similar Matl
$21.59
-2.06% 1D
Market Cap $3.8B
TTM Revenue $749M
Forward P/E 50.8x
Beta / 30D Vol 1.09β · 58% Vol
Unified Composite Score
42.1 / 100 HOLD
Tech 30.0 Fund 34.0 Flow 68.0 Mom 1.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (17.4% over 20 days), RSI 58
RSI-14: 58.4 · SMA20: $21.16 · SMA50: $17.22

6-Pillar Scorecard Institutional Category Breakdown (DOCS 4 – 2 FIGS)

Columns: Metric · DOCS · FIGS
1. Valuation Multiples DOCS
Forward P/E 20.6x 50.8x
Trailing P/E 46.1x 59.7x
PEG Ratio 0.59x N/M
EV / Revenue 8.6x 5.0x
2. Growth & Scale FIGS
Revenue Growth (YoY) +3.6% +25.7%
Earnings Growth (YoY) -41.9% +100.0%
TTM Revenue (USD) $662M $749M
Market Cap $5.9B $3.8B
3. Profitability & Quality DOCS
Gross Margin 86.8% 67.7%
Operating Margin 27.1% 9.7%
Net Profit Margin 21.1% 9.7%
Return on Equity (ROE) 13.8% 16.8%
4. Balance Sheet & Cash Flow DOCS
Cash Generation (TTM) $297M $148M
Cash Flow Margin 44.9% 19.7%
Net Cash / Leverage $209M Net Cash $9.5M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning FIGS
Options Structure Phase SURGE BREAKOUT
Current IV / %ile 42.5% (33rd %ile) 58.8% (21st %ile)
Put/Call OI Skew 0.14x (Call-Skewed) 0.14x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat DOCS
OpEx & R&D Intensity 59.7% of Rev ($395M) 58.0% of Rev ($434M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Health Information Services Operator Apparel Manufacturing Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DOCS (7) vs FIGS (3)
Institutional Metric DOCS FIGS Criterion Row Edge
Market Capitalization
Scale
$5.9B $3.8B Larger Scale DOCS
Trailing P/E Ratio
Valuation
46.1x 59.7x Lower Multiple DOCS
Forward P/E Ratio
Valuation
20.6x 50.8x Lower Multiple DOCS
Revenue Growth (YoY)
Growth
+3.6% +25.7% Higher Growth FIGS
Operating Margin (TTM)
Profitability
27.1% 9.7% Higher Margin DOCS
Net Profit Margin
Profitability
21.1% 9.7% Higher Margin DOCS
Return on Equity (ROE)
Capital Efficiency
13.8% 16.8% Higher ROE FIGS
52-Week Range Position
Momentum
45% ($17–$52) 85% ($9–$24) Stronger Trend FIGS
Beta / 30D Volatility
Risk Regime
0.65β · 41% Vol 1.09β · 58% Vol Lower Realized Risk DOCS
Unified Institutional Score
Composite Signal
54.4 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite DOCS
Trailing 12M Revenue (USD)
Operating Scale
$662M $749M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
86.8% 67.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.59x PEG · 8.6x EV/Rev N/M PEG · 5.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$297M ($209M Net Cash) $148M ($9.5M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FIGS +7.45 pp
DOCS: +5.49% · FIGS: +12.94%
3M Horizon FIGS +21.52 pp
DOCS: +30.99% · FIGS: +52.51%
6M Horizon FIGS +20.93 pp
DOCS: +66.85% · FIGS: +87.78%
1Y Horizon FIGS +164.02 pp
DOCS: -34.29% · FIGS: +129.73%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period DOCS Revenue FIGS Revenue DOCS Op. Margin FIGS Op. Margin Margin Leader
FY2019 N/A $110M N/A -0.3% FIGS
FY2020 $120M $260M 19.0% 22.0% FIGS
FY2021 $210M $420M 25.8% 2.6% DOCS
FY2022 $340M $510M 33.0% 7.4% DOCS
FY2023 $420M $550M 29.9% 6.2% DOCS
FY2024 $480M $560M 34.5% 0.4% DOCS
FY2025 $570M $630M 39.9% 6.0% DOCS
FY2026 $640M N/A 33.3% N/A DOCS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DOCS SURGE
13d in phase · OBV DISTRIBUTION
Current IV 42.5%
IV Percentile 33rd %ile
Put/Call OI Skew 0.14x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact DOCS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FIGS BREAKOUT
22d in phase · OBV NEUTRAL
Current IV 58.8%
IV Percentile 21st %ile
Put/Call OI Skew 0.14x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact FIGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DOCS Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $5.9B market capitalization and 27.1% operating margin.
OpEx & R&D Reinvestment 59.7% of Rev ($395M)
90D Engineering Disclosures 0 Published
FIGS Moat Profile Cyclical / Execution-Driven Positioning
Apparel Manufacturing Operator
Competes within the Apparel Manufacturing value chain with $3.8B market capitalization and 9.7% operating margin.
OpEx & R&D Reinvestment 58.0% of Rev ($434M)
90D Engineering Disclosures 0 Published

Investor FAQ DOCS vs FIGS Key Questions & Quantitative Answers

As of Nov 16, 2026, Doximity, Inc. (DOCS) is the stronger overall head-to-head candidate over FIGS, Inc. (FIGS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). DOCS carries a Unified Composite Score of 54.4/100 (HOLD) at $32.67 (20.6x Forward P/E, 27.1% operating margin), whereas FIGS carries 42.1/100 (HOLD) at $21.59 (50.8x Forward P/E, 9.7% operating margin). Growth vs. Quality Trade-Off: DOCS earns the overall head-to-head edge with a stronger Unified Composite Score (54.4/100 HOLD vs. FIGS 42.1/100 HOLD) and 0.65β · 41% Vol risk profile, whereas FIGS leads top-line expansion (+25.7% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.

FIGS leads the Growth & Scale pillar: DOCS posts +3.6% YoY revenue growth and -41.9% YoY earnings growth on $662M TTM revenue (86.8% gross margin, 27.1% operating margin), compared with FIGS at +25.7% YoY revenue growth and +100.0% YoY earnings growth on $749M TTM revenue (67.7% gross margin, 9.7% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), DOCS cumulative revenue shifted +433.3% while FIGS shifted +472.7%. In operating R&D and SG&A reinvestment, DOCS deploys 59.7% of Rev ($395M) (0 90-day corporate R&D disclosures) versus 58.0% of Rev ($434M) (0 disclosures) for FIGS.

DOCS screens cheaper on headline valuation multiples. DOCS trades at 20.6x Forward P/E, 46.1x Trailing P/E, 0.59x PEG, and 8.6x EV/Revenue (44.9% FCF margin), whereas FIGS trades at 50.8x Forward P/E, 59.7x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (19.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DOCS (13.8% ROE) versus FIGS (16.8% ROE) capital efficiency.

In options market volatility and institutional positioning, DOCS carries 42.5% implied volatility (33rd %ile, Balanced (25th–60th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.65β · 41% Vol realized risk). By comparison, FIGS carries 58.8% implied volatility (21st %ile, Compressed (<25th %ile)), a 0.14x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (1.09β · 58% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.